Skip to main content

Table 7 Use of biomarkers and e-health in AIT randomized controlled trials

From: Allergen Immunotherapy (AIT): a prototype of Precision Medicine

EAACI AIT outcomes

e-health and biomarkers

Total symptom score

Included in VASa

Total medication score

Standardised by ICPs and CDSS

Total symptom-medication score

Standardised by ICPs and CDSS

Quality-of-Life

Included in VASa

Well days

Standardised by ICPs and CDSS

Days with severe symptoms

Standardised by ICPs and CDSS

Global assessment of patient satisfaction

Recorded by telemedicine

  1. aIn 2 cluster randomized trials of 595 and 537 patients (one in secondary care, one in primary care) [43, 44], the VAS level change during treatment incorporated symptom and RQLQ information.